All these results indicate that FGFRL1 can promote bladder cancer growth and metastasis in vitro and in vivo, and miR-210-3p plays an important role in the inhibition of bladder cancer growth and metastasis through targeting FGFRL1. Here, FGFRL1 is linked to urinary bladder carcinoma.